Lancet Diabetes Endocrinol: Global Diabetes Mortality and Pre-25 Trends in 2019: Analysis of the Global Burden of Disease Study

Diabetes has been identified by the United Nations as one of the top five non-communicable diseases and included in its action plan to address the challenges of non-communicable diseases

Diabetes has been identified by the United Nations as one of the top five non-communicable diseases and included in its action plan to address the challenges of non-communicable diseases

Many low- and middle-income countries have made considerable progress in providing the most basic key measures to prevent death from acute complications of diabetes

Because mortality data are the most available health statistics in the world, they can be used to track levels and trends in essential diabetes care

The Global Burden of Disease, Injury and Risk Factors Study (GBD), which systematically collects mortality data, provides estimates of mortality by age group and disease for countries around the world

Methods: In 1990 and 2019, researchers used estimates from GBD2019 to calculate international diabetes mortality under age 25

Methods: In 1990 and 2019, researchers used estimates from GBD2019 to calculate international diabetes mortality under age 25

Research result:

Research result:

In 2019, of the 16,300 (95% uncertainty interval, 14,200 to 18,900) deaths worldwide from diabetes ( combined type 1 and type 2) among people under the age of 25 , 73.

In 2019, of the 16,300 (95% uncertainty interval, 14,200 to 18,900) deaths worldwide from diabetes ( combined type 1 and type 2) among people under the age of 25 , 73.

The age-standardized mortality rate was 0.

The rate was 0.

Within the SDI quintiles, we observed large differences in rates between countries, in part due to the extent of UHC (r² = 0 62);

From 1990 to 2019, the age-standardized mortality rate for all diabetes decreased by 17.

From 1990 to 2019, the age-standardized mortality rate for all diabetes decreased by 17.

However, lower SDI quintiles decreased for all diabetes (–13 6% [–28 4 to 3 4]) and type 1 diabetes (–13 6% [–29 3 to 8 9]) the smallest amplitude

Reducing diabetes mortality under 25 years of age remains an important challenge, especially in low and moderately low SDI countries

Source: GBD 2019 Diabetes Mortality Collaborators.
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019.
Lancet Diabetes Endocrinol.
2022;10(3):177-192.
doi:10.
1016/S2213 -8587(21)00349-1 GBD 2019 Diabetes Mortality Collaborators.
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019.
Lancet Diabetes Endocrinol.
2022;10(3):177-192.
doi:10.
1016/S2213-8587(21)00349-1Leave

a message here